ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,669Medicare Part D Prescriptions Filled, Including Refills

Rank: 249 out of 1121

$640K Total Retail Price of All Prescriptions

Rank: 261 out of 1121

711 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
11% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

3% of this provider’s 711 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 11,085 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
SIMVASTATIN 828 758 1 1
LOSARTAN POTASSIUM 780 761 2 17
AMLODIPINE BESYLATE 583 551 3 5
LEVOTHYROXINE SODIUM 524 502 4 2
OMEPRAZOLE 393 379 5 6
METFORMIN HCL 387 361 6 8
LOSARTAN-HYDROCHLOROTHIAZIDE 358 328 7 46
ATORVASTATIN CALCIUM 314 299 8 15
LISINOPRIL 310 282 9 4
FUROSEMIDE 233 225 10 7
METOPROLOL SUCCINATE 204 198 11 23
ATENOLOL 196 188 12 16
TAMSULOSIN HCL 180 180 13 32
POTASSIUM CHLORIDE 167 162 14 12
ZOLPIDEM TARTRATE 167 166 14 19
HYDROCHLOROTHIAZIDE 142 139 16 10
METOPROLOL TARTRATE 142 124 16 9
CRESTOR 126 111 18 28
SERTRALINE HCL 117 117 19 21
GABAPENTIN 115 107 20 13
ALLOPURINOL 109 94 21 30
TRAMADOL HCL 108 108 22 25
SYNTHROID 107 107 23 55
TRIAMTERENE-HCTZ 106 104 24 38
GLIPIZIDE XL 98 98 25 256
CITALOPRAM HBR 97 97 26 18
KLOR-CON 10 96 69 27 69
NAMENDA 91 91 28 53
NEXIUM 90 72 29 24
PRAVASTATIN SODIUM 87 86 30 14
LISINOPRIL-HYDROCHLOROTHIAZIDE 83 76 31 31
DONEPEZIL HCL 81 81 32 35
FINASTERIDE 77 74 33 117
FLUOXETINE HCL 76 65 34 60
CLOPIDOGREL 76 73 34 27
JANUVIA 75 75 36 81
MELOXICAM 73 72 37 22
METFORMIN HCL ER 70 68 38 47
DIOVAN 70 64 38 45
GLIPIZIDE ER 69 68 40 142
CLONIDINE HCL 69 61 40 39
LIPITOR 66 64 42 106
ISOSORBIDE MONONITRATE ER 62 62 43 62
BUSPIRONE HCL 61 60 44 114
CIPROFLOXACIN HCL 61 60 44 57
WARFARIN SODIUM 60 50 46 11
ZOSTAVAX 59 55 47 268
CARVEDILOL 56 56 48 20
PROPRANOLOL HCL 55 55 49 123
DOXAZOSIN MESYLATE 54 50 50 93
PAROXETINE HCL 52 52 51 58
ALPRAZOLAM 52 52 51 472
PLAVIX 52 50 51 42
TRAZODONE HCL 51 49 54 40
CHLORTHALIDONE 51 50 54 149
RANITIDINE HCL 50 50 56 33
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 8, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.